Serina Therapeutics Q1 2026 Earnings EPS Misses Estimates as Stock Climbs Despite Loss NCTY Q1 2012 Earnings Narrower Loss Than Expected as Revenue Picture Remains Unclear SPOK Q1 2026 Earnings EPS Misses Estimates by 51 Revenue Data Unavailable The RealReal Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline CING Q1 2026 Earnings Deep EPS Miss Overshadowed by Positive Stock Movement LNKB Q4 2025 Earnings Earnings Miss Highlights Persistent Headwinds